513.72
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ISRG Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$512.23
Aprire:
$512.51
Volume 24 ore:
986.37K
Relative Volume:
0.57
Capitalizzazione di mercato:
$184.24B
Reddito:
$8.71B
Utile/perdita netta:
$2.48B
Rapporto P/E:
75.33
EPS:
6.82
Flusso di cassa netto:
$1.75B
1 W Prestazione:
-2.67%
1M Prestazione:
-0.96%
6M Prestazione:
-11.99%
1 anno Prestazione:
+17.36%
Intuitive Surgical Inc Stock (ISRG) Company Profile
Nome
Intuitive Surgical Inc
Settore
Industria
Telefono
(408) 523-2100
Indirizzo
1020 KIFER ROAD, SUNNYVALE
Confronta ISRG con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
ISRG
Intuitive Surgical Inc
|
514.03 | 188.99B | 8.71B | 2.48B | 1.75B | 6.82 |
![]()
BDX
Becton Dickinson Co
|
178.82 | 50.05B | 20.87B | 1.50B | 2.59B | 5.24 |
![]()
ALC
Alcon Inc
|
86.64 | 43.06B | 9.93B | 1.12B | 1.58B | 2.25 |
![]()
RMD
Resmed Inc
|
253.63 | 37.62B | 5.02B | 1.31B | 1.56B | 8.91 |
![]()
WST
West Pharmaceutical Services Inc
|
224.01 | 15.84B | 2.90B | 467.20M | 306.90M | 6.37 |
Intuitive Surgical Inc Stock (ISRG) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-06-09 | Downgrade | Deutsche Bank | Hold → Sell |
2025-06-05 | Aggiornamento | Erste Group | Hold → Buy |
2024-12-02 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
2024-08-02 | Aggiornamento | Redburn Atlantic | Neutral → Buy |
2024-07-10 | Reiterato | Citigroup | Buy |
2024-05-30 | Iniziato | Goldman | Buy |
2023-11-17 | Iniziato | HSBC Securities | Buy |
2023-07-19 | Iniziato | Robert W. Baird | Outperform |
2023-04-19 | Reiterato | BTIG Research | Buy |
2023-04-19 | Reiterato | BofA Securities | Buy |
2023-04-19 | Reiterato | Citigroup | Buy |
2023-04-19 | Reiterato | Evercore ISI | In-line |
2023-04-19 | Reiterato | JP Morgan | Overweight |
2023-04-19 | Reiterato | Morgan Stanley | Equal-Weight |
2023-04-19 | Reiterato | RBC Capital Mkts | Outperform |
2023-04-19 | Reiterato | Raymond James | Outperform |
2023-04-19 | Reiterato | Stifel | Buy |
2023-04-19 | Reiterato | Truist | Buy |
2023-04-19 | Reiterato | Wells Fargo | Overweight |
2023-03-29 | Iniziato | UBS | Neutral |
2023-03-23 | Iniziato | William Blair | Outperform |
2022-10-18 | Iniziato | Barclays | Overweight |
2022-10-13 | Iniziato | Mizuho | Neutral |
2022-10-12 | Iniziato | Jefferies | Hold |
2022-04-13 | Iniziato | Truist | Buy |
2022-04-06 | Iniziato | Wolfe Research | Peer Perform |
2022-03-25 | Iniziato | RBC Capital Mkts | Outperform |
2022-03-02 | Ripresa | BofA Securities | Buy |
2022-02-02 | Aggiornamento | UBS | Neutral → Buy |
2022-01-31 | Aggiornamento | Piper Sandler | Neutral → Overweight |
2022-01-25 | Downgrade | Redburn | Buy → Neutral |
2022-01-21 | Reiterato | BTIG Research | Buy |
2022-01-21 | Aggiornamento | Citigroup | Neutral → Buy |
2022-01-21 | Reiterato | Deutsche Bank | Hold |
2022-01-21 | Reiterato | Evercore ISI | In-line |
2022-01-21 | Reiterato | Morgan Stanley | Equal-Weight |
2022-01-21 | Reiterato | Piper Sandler | Neutral |
2022-01-21 | Reiterato | Raymond James | Outperform |
2022-01-21 | Reiterato | Robert W. Baird | Outperform |
2022-01-21 | Reiterato | Stifel | Buy |
2022-01-21 | Reiterato | UBS | Neutral |
2022-01-21 | Reiterato | Wells Fargo | Overweight |
2022-01-10 | Aggiornamento | BTIG Research | Neutral → Buy |
2021-10-01 | Downgrade | Citigroup | Buy → Neutral |
2021-07-21 | Reiterato | BofA Securities | Neutral |
2021-07-21 | Reiterato | Citigroup | Buy |
2021-07-21 | Reiterato | JP Morgan | Overweight |
2021-07-21 | Reiterato | Morgan Stanley | Equal-Weight |
2021-07-21 | Reiterato | Piper Sandler | Neutral |
2021-07-21 | Reiterato | SVB Leerink | Mkt Perform |
2021-07-21 | Reiterato | Stifel | Buy |
2021-07-21 | Reiterato | UBS | Neutral |
2021-07-21 | Reiterato | Wells Fargo | Overweight |
2021-07-14 | Reiterato | Goldman | Buy |
2021-06-01 | Aggiornamento | Evercore ISI | Underperform → In-line |
2021-04-21 | Aggiornamento | Oppenheimer | Underperform → Perform |
2021-04-21 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
2021-04-01 | Iniziato | Citigroup | Buy |
2020-12-15 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
2020-09-28 | Iniziato | Argus | Buy |
2020-09-11 | Iniziato | Wolfe Research | Outperform |
2020-09-08 | Downgrade | BofA Securities | Buy → Neutral |
2020-09-02 | Iniziato | Robert W. Baird | Neutral |
2020-07-20 | Reiterato | Bernstein | Outperform |
2020-04-28 | Downgrade | Piper Sandler | Overweight → Neutral |
2020-04-17 | Downgrade | CFRA | Hold → Sell |
2020-04-17 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
2020-04-09 | Downgrade | Evercore ISI | In-line → Underperform |
2020-04-01 | Downgrade | Oppenheimer | Perform → Underperform |
2020-01-27 | Downgrade | Deutsche Bank | Buy → Hold |
2019-12-12 | Reiterato | Wells Fargo | Outperform |
2019-11-21 | Iniziato | Oppenheimer | Perform |
2019-07-19 | Reiterato | Canaccord Genuity | Buy |
2019-04-22 | Reiterato | Canaccord Genuity | Buy |
2019-04-02 | Iniziato | Deutsche Bank | Buy |
2018-10-31 | Reiterato | Piper Jaffray | Overweight |
2018-10-19 | Aggiornamento | Canaccord Genuity | Hold → Buy |
Mostra tutto
Intuitive Surgical Inc Borsa (ISRG) Ultime notizie
Intuitive Surgical (ISRG) Showcases Transatlantic Telesurgery Capabilities in Strasbourg Conference - simplywall.st
BTIG Raises Intuitive Surgical (ISRG) Price Target, Maintains Buy Rating - Insider Monkey
Intuitive Surgical (ISRG) Showcases Telesurgery Innovation | ISR - GuruFocus
Intuitive demonstrates transatlantic telesurgery capabilities By Investing.com - Investing.com South Africa
Intuitive demonstrates telesurgery capabilities | ISRG Stock New - GuruFocus
Intuitive Showcases Telesurgery Innovation at Society of Robotic Surgery Conference - Quiver Quantitative
Intuitive demonstrates telesurgery capabilities - GlobeNewswire
Surgeons Control Robotic System Across 4,000 Miles in Groundbreaking Telesurgery Achievement - Stock Titan
AI Based Surgical Robots Market Set to Witness Significant - openPR.com
This Startup Wants Its Robots To Operate On Your Eyeballs - Forbes Africa
Medtronic’s Hugo robot wins CE mark for vessel-sealing technology - Yahoo
Intuitive Surgical, Inc. (ISRG) Is a Trending Stock: Facts to Know Before Betting on It - MSN
FDA Approves Intuitive Surgical (ISRG) Vessel Sealer Curved Surgical Instrument - MSN
Spine Surgery Robots Market Surging with Minimally Invasive - openPR.com
Intuitive Surgical Price Target Boosted Ahead of Earnings - AInvest
Intuitive Surgical Sees $10.78 Billion Trading Volume Despite 28.74% Decline - AInvest
BTIG Adjusts Price Target on Intuitive Surgical to $566 From $542 - MarketScreener
Why Intuitive Surgical Inc. stock attracts strong analyst attentionFree Predictions - beatles.ru
Hospital Capex Headwind: Temporary Setback or Lasting Risk for ISRG? - Yahoo Finance
FDA Approves Intuitive Surgical’s (ISRG) New Vessel Sealer Tool - MSN
Intuitive Surgical (ISRG) Target Price Boosted Amid MedTech Sect - GuruFocus
FDA clears Intuitive’s Vessel Sealer Curved for use with da Vinci systems - Yahoo
Healthcare Metaverse Market Top PlayersIntuitive Surgical - openPR.com
How to Take Advantage of moves in (ISRG) - news.stocktradersdaily.com
Options Trading Signals for Intuitive Surgical: A Bearish Outlook for the Robotics Company - AInvest
Intuitive Surgical to demolish buildings in Tech Park - Peachtree Corners Magazine
Surgical Robot Maker to Become City’s Biggest Employer with $540M Campus Expansion - Peachtree Corners Magazine
Medical Technology Company Intuitive Expanding in Peachtree Corners, Adding Approximately 1,200 New Jobs - Peachtree Corners Magazine
10 Brilliant Growth Stocks to Buy Now and Hold for the Long Term - The Motley Fool
Why Intuitive Surgical, Inc. (ISRG) Dipped More Than Broader Market Today - MSN
RETO files 6-K/A with audited MeinMalzeBier financials & pro forma data | ISRG SEC FilingForm 4 - Stock Titan
U.S. Physical Therapy, Evolent Health, Charles River Laboratories, Moderna, and Intuitive Surgical Shares Are Falling, What You Need To Know - Yahoo Finance
Intuitive Surgical Slides Below Key Support—What’s Driving the Drop? - AInvest
Intuitive Surgical: A Leadership That Is Hard To Extirpate (NASDAQ:ISRG) - Seeking Alpha
FDA clears Intuitive curved vessel sealer device for surgical robot - MassDevice
Intuitive Surgical Gets FDA Clearance For Advanced Energy Surgical Instrument: Retail Sentiment Improves - Stocktwits
Intuitive wins FDA nod for Vessel Sealer Curved (ISRG:NASDAQ) - Seeking Alpha
Intuitive Surgical's Vessel Sealer Curved Gets FDA Clearance - Nasdaq
Intuitive Surgical (ISRG) Gains FDA Nod for Innovative Surgical Tool | ISRG Stock News - GuruFocus
Intuitive Receives FDA Clearance for Vessel Sealer Curved, Advancing Robotic-Assisted Surgery Innovation - Quiver Quantitative
Vessel Sealer Curved receives FDA clearance - GlobeNewswire
Breakthrough FDA Clearance: Intuitive's Curved Vessel Sealer Transforms Robotic Surgery Precision - Stock Titan
Intuitive Surgical’s Da Vinci 5 System Receives CE Mark, Expands Advanced Robotic Surgery Access Across Europe - Yahoo Finance
Evercore ISI Lifts Price Target on Intuitive Surgical to $550 From $470, Maintains In Line Rating - MarketScreener
Intuitive Surgical (ISRG) Price Target Raised by Evercore ISI Gr - GuruFocus
ISRG Expands Installed Base, But Is Utilization Keeping Pace? - Yahoo Finance
Intuitive Surgical, Inc. (ISRG) Suffers a Larger Drop Than the General Market: Key Insights - Nasdaq
Intuitive Surgical investor Keown launches his own startup to rethink outpatient surgery - Global Venturing
Intuitive Surgical's Fifth Generation da Vinci System Receives CE Mark - Nasdaq
Intuitive Surgical obtains CE mark for da Vinci 5 robot - The Robot Report
da Vinci 5 Surgical System approved in Europe - Urology Times
Intuitive Surgical Inc Azioni (ISRG) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):